BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Cisplatin
,
rs6983267
,
IL1A
,
calcium channel activity
,
Hepatitis
,
Lymphocyte
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
muromonab cd3
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
KCNJ5
LEP
RARRES1
HIST2H3A
HS3ST2
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
FISCHER_DREAM_TARGETS
HAY_BONE_MARROW_ERYTHROBLAST
DODD_NASOPHARYNGEAL_CARCINOMA_DN
KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP
PUJANA_BRCA1_PCC_NETWORK
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
CD4+ T cells stimulated and then restimulated in the presence or absence of natalizumab
Influence of anti-CD25 mAb on the transcriptome of activated PBMC
T-cells from healthy donor-derived PBMC after treatment with anti-CD3 antibodies
Explore Curated Studies Results
Literature
Most Relevant Literature
A multi-functional drug delivery nanosystem release of TLR-7 immunostimulant and OKT3 induced effici…
Nanovesicles released by OKT3 hybridoma express fully active antibodies.
Myeloid and dendritic cells enhance therapeutics-induced cytokine release syndrome features in human…
Peripheral T-cell lymphoma immunophenotype in a patient with a history of Muromonab-CD3 therapy: A c…
Genetic code expansion in E. coli enables production of a functional 'ready-to-click' T cell recepto…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Phase II Randomized Study of Muromonab-CD3, Cyclosporine, Methylprednisolone, and Prednisone in Pati…
Study of Muromonab-CD3 and Cyclosporine in Patients With Giant Cell Myocarditis
Donor Peripheral Stem Cell Transplant and Donor Natural Killer Cell Transplant After Total-Body Irra…
Randomized, Multicenter, 2-Dose Level. Open-Label, Phase IIa Study With the Intraperitoneally Infuse…
Monoclonal Antibody Plus Cyclophosphamide in Treating Patients With Metastatic Cancer
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ